Advances in precision medicine — time for a new journal

Authors

  • Lilla Landeck
  • Robert L Holland
  • Khusru Asadullah

DOI:

https://doi.org/10.18063/APM.2016.01.005

Abstract

N/A

References

Collins F S and Varmus H, 2015, A new initiative on precision medicine. New England Journal of Medicine, vol.372: 793–795.

Watson J D and Crick F H, 1953. Molecular structure of nucleic acids. A structure for deoxyribose nucleic acid. Nature, vol.171: 737–738.

European Union: Strategic Research Agenda for Innovative Medicines Initiative, n.d., accessed December 22, 2015, <http://www.efpia.eu/uploads/Modules/Documents/def_efpia_brochure_sra_a4_web.pdf>

Biomarkers Definitions Working Group, 2001, Bio-markers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology, vol.69: 89–95.

Landeck L, Kneip C, Reischl J, et al. 2015, Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology, accepted for Experimental Dermatology.

Table of Pharmacogenomic Biomarkers in Drug Labe-ling, n.d., accessed 22 December 2015, <http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm>

Poste G, 2011, Bring on the biomarkers. Nature, vol.469: 156–157.

Prinz F, Schlange T, Asadullah K, et al. 2011, Believe it nor not — how much can we rely on published data? Nature Reviews Drug Discovery, vol.10: 712.

Asadullah K, Busch A, Gottwald G, et al. 2015, Industrial–academic collaborations for biomarkers. Nature Reviews Drug Discovery, vol.14: 805–806.

Salter H and Holland R, 2014, Biomarkers: refining diagnosis and expediting drug development — reality, aspiration and the role of open innovation. Journal of Internal Medicine, vol. 276: 215–228.

Downloads

Published

2016-03-18

Issue

Vol 1, Issue 1

Section

Editorials

License

Authors contributing to Advances in Precision Medicine agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear.